Pfützner Andreas, Jensch Hendrick, Cardinal Christopher, Srikanthamoorthy Geetham, Riehn Eric, Thomé Nicole
Pfützner Science & Health Institute, Mainz, Germany.
University for Digital Technologies in Medicine and Dentistry, Wiltz, Luxembourg.
J Diabetes Sci Technol. 2024 Jan;18(1):59-65. doi: 10.1177/19322968221095573. Epub 2022 May 13.
Testing the potential influence of interfering substances on the measurement performance of needle sensors for continuous glucose monitoring (CGM) is a challenging task. For proper function, the sensors need an almost stable fluidic environment. Previously published in vitro interference experiments were measuring under static concentration conditons. Our experimental setup allows for interference testing with dynamic changes of the interferent concentrations.
We designed a macrofluidic test stand that is fueled by several high-pressure liquid chromatography (HPLC) pumps generating programmable glucose and/or interferent gradients in phosphate-buffered saline (PBS). After optimizing experimental parameters (channel dimensions, temperature, flow rates, gradient slopes, buffer, pH etc.), we validated the setup using Dexcom G6 (G6) and Freestyle Libre 2 (L2) sensors with/without interferents, and using YSI 2300 Stat plus as the reference glucose device at room temperature.
Both sensors tracked the programmed glucose changes. After calibration, G6 results closely matched glucose reference readings, while L2 routinely showed ~50% to 60% lower readings, most likely because of the factory-based calibration and temperature compensation. Gradients of maltose, acetaminophen, and xylose were employed to further validate the setup. As expected, both sensors were not affected by maltose. We confirmed previous findings regarding susceptibility of G6 readings to acetaminophen and L2 readings to xylose. Signals from both sensors are influenced by temperature in a linear fashion.
Our experimental in vitro setup and protocol may provide a useful method to dynamically test CGM sensors for interfering substances. This may help to improve the accuracy of future CGM sensor generations.
测试干扰物质对连续血糖监测(CGM)针刺传感器测量性能的潜在影响是一项具有挑战性的任务。为实现正常功能,传感器需要几乎稳定的流体环境。先前发表的体外干扰实验是在静态浓度条件下进行测量的。我们的实验装置允许在干扰物浓度动态变化的情况下进行干扰测试。
我们设计了一个宏观流体测试台,由几台高压液相色谱(HPLC)泵提供动力,在磷酸盐缓冲盐水(PBS)中生成可编程的葡萄糖和/或干扰物梯度。在优化实验参数(通道尺寸、温度、流速、梯度斜率、缓冲液、pH值等)后,我们使用带/不带干扰物的德康G6(G6)和自由风格 Libre 2(L2)传感器,并在室温下使用 YSI 2300 Stat plus作为参考葡萄糖设备对该装置进行了验证。
两种传感器都跟踪了编程的葡萄糖变化。校准后,G6的结果与葡萄糖参考读数密切匹配,而L2的读数通常低约50%至60%,这很可能是由于基于工厂的校准和温度补偿。使用麦芽糖、对乙酰氨基酚和木糖的梯度进一步验证该装置。正如预期的那样,两种传感器均未受到麦芽糖的影响。我们证实了先前关于G6读数对乙酰氨基酚的敏感性以及L2读数对木糖的敏感性的研究结果。两种传感器的信号都受到温度的线性影响。
我们的体外实验装置和方案可能提供一种有用的方法来动态测试CGM传感器是否存在干扰物质。这可能有助于提高未来几代CGM传感器的准确性。